Dr. Veronica Kon Graversen, M.D.
What this data tells you about Dr. Kon Graversen
Dr. Veronica Kon Graversen is an ophthalmology in Fort Myers, FL, with 15 years in practice. Based on federal Medicare data, Dr. Kon Graversen performed 32,156 Medicare services across 6,372 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kon Graversen received a total of $774 from 7 pharmaceutical and/or device companies across 11 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kon Graversen is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) | 13,980 | $29 | $76 |
| Injection, ranibizumab, 0.1 mg | 4,000 | $179 | $695 |
| Retinal photography (fundus photo) | 3,399 | $29 | $103 |
| Retinal imaging (OCT scan) | 3,336 | $31 | $85 |
| Eye injection for retinal disease | 1,959 | $100 | $259 |
| Aflibercept eye injection (Eylea) | 1,652 | $690 | $1,890 |
| Comprehensive eye exam, established patient | 1,004 | $87 | $260 |
| Eye exam, established patient, focused | 659 | $63 | $182 |
| New patient office visit (45-59 min) | 374 | $123 | $348 |
| Unclassified drugs | 348 | $208 | $923 |
| Office visit, established patient (20-29 min) | 308 | $73 | $158 |
| Exam of retinal blood vessels using a special camera after injection of a dye | 294 | $106 | $214 |
| Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 213 | $214 | $544 |
| Injection, dexamethasone, intravitreal implant, 0.1 mg | 133 | $158 | $400 |
| Office visit, established patient (30-39 min) | 102 | $104 | $228 |
| 2d ultrasound scan of eye tissue and structures | 100 | $37 | $109 |
| Comprehensive eye exam, new patient | 99 | $109 | $309 |
| Photocoagulation treatment to prevent detachment of retina | 35 | $194 | $1,143 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 29 | $17 | $48 |
| Removal of membrane of retina | 25 | $918 | $2,428 |
| Visual field test, extended | 23 | $49 | $130 |
| Heat or freezing treatment to prevent detachment of retina | 20 | $216 | $1,103 |
| Repair of detached retina with drainage and removal of eye fluid between lens and retina | 19 | $912 | $2,527 |
| Removal of membrane of retina with removal of internal limiting membrane of retina | 16 | $908 | $2,427 |
| Extended exam of the back part of the eye with retinal drawing | 16 | $16 | $53 |
| Repair of detached retina by injection of air or gas | 13 | $702 | $1,865 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
3.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kon Graversen is a mixed practice specialist, with above-average Medicare volume (top 4% in FL), and low-engagement industry engagement, with 15 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kon Graversen experienced with eye injection (vabysmo/faricimab)?
Does Dr. Kon Graversen receive payments from pharmaceutical companies?
How do Dr. Kon Graversen's costs compare to other ophthalmologys in Fort Myers?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology